Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$113M |
| 2 |
Amazon
AMZN
|
+$61.7M |
| 3 |
Alibaba
BABA
|
+$39.9M |
| 4 |
CTEV
Claritev Corp
CTEV
|
+$30.3M |
| 5 |
WPF.U
Foley Trasimene Acquisition Corp.
WPF.U
|
+$28.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$37M |
| 2 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30M |
| 3 |
JD.com
JD
|
+$29.9M |
| 4 |
Bilibili
BILI
|
+$29.5M |
| 5 |
CCX.U
Churchill Capital Corp II
CCX.U
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Financials | 10.94% |
| 4 | Industrials | 10.2% |
| 5 | Healthcare | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Marvell Technology
MRVL
$213B
| $1.34M | 0.03% |
38,097
+11,660
| +44% | +$341K |
|
527
Diageo
DEO
$52.6B
| $1.33M | 0.03% |
+9,922
| New | +$1.36M |
|
528
Arch Capital
ACGL
$33.9B
| $1.33M | 0.03% |
46,431
-37,629
| -45% | -$1.04M |
|
529
Microsoft
MSFT
$3.59T
| $1.32M | 0.03% |
6,500
-89,871
| -93% | -$16.3M |
|
530
Builders FirstSource
BLDR
$7.55B
| $1.32M | 0.03% |
63,647
-28,853
| -31% | -$521K |
|
531
Booz Allen Hamilton
BAH
$9.27B
| $1.31M | 0.03% |
16,858
-3,536
| -17% | -$267K |
|
532
Toll Brothers
TOL
$13.7B
| $1.31M | 0.03% |
40,161
-186,139
| -82% | -$5.09M |
|
|
JHG
533
DELISTED
Janus Henderson
JHG
| $1.31M | 0.03% |
+61,782
| New | +$1.19M |
|
534
Markel Group
MKL
$22.2B
| $1.3M | 0.03% |
1,405
+893
| +174% | +$812K |
|
535
Warner Bros
WBD
$71.6B
| $1.29M | 0.03% |
61,376
+30,196
| +97% | +$652K |
|
|
AMED
536
DELISTED
Amedisys
AMED
| $1.29M | 0.03% |
+6,519
| New | +$1.22M |
|
537
Hilton Worldwide
HLT
$73.5B
| $1.29M | 0.03% |
17,529
+10,569
| +152% | +$784K |
|
538
Western Union
WU
$2.28B
| $1.28M | 0.03% |
59,420
+30,509
| +106% | +$619K |
|
|
PAE
539
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $1.28M | 0.03% |
134,397
-353,161
| -72% | -$3.14M |
|
540
Clorox
CLX
$12.9B
| $1.28M | 0.03% |
5,836
-4,096
| -41% | -$818K |
|
|
DQ
541
Daqo New Energy
DQ
$919M
| $1.28M | 0.03% |
86,170
+66,415
| +336% | +$727K |
|
542
OrthoPediatrics
KIDS
$670M
| $1.27M | 0.03% |
+28,937
| New | +$1.3M |
|
543
Travel + Leisure Co
TNL
$4.39B
| $1.26M | 0.03% |
44,722
+23,722
| +113% | +$642K |
|
544
Genpact
G
$6.24B
| $1.26M | 0.03% |
34,373
+17,224
| +100% | +$582K |
|
|
SPR
545
DELISTED
Spirit AeroSystems
SPR
| $1.25M | 0.03% |
+52,400
| New | +$1.19M |
|
546
Air Products & Chemicals
APD
$67.9B
| $1.25M | 0.03% |
5,176
-3,496
| -40% | -$798K |
|
547
Trex
TREX
$4.77B
| $1.25M | 0.03% |
19,132
-338
| -2% | -$18K |
|
548
Molson Coors Class B
TAP
$8.01B
| $1.24M | 0.03% |
+36,087
| New | +$1.44M |
|
549
Mustang Bio
MBIO
$4.39M
| $1.24M | 0.03% |
+518
| New | +$1.21M |
|
|
DCPH
550
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.23M | 0.03% |
+20,659
| New | +$1.11M |
|
Similar funds
Steve Schonfeld's Q2 2020 Portfolio in Review
As of Q2 2020, Steve Schonfeld held 1,688 positions worth $3.89B, up 145% from $1.59B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Steve Schonfeld deployed $1.81B of net new capital in Q2 2020, opening 594 new positions and adding to 357 existing holdings. Its largest new stake was Claritev Corp: 75,000 shares worth $32.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was JD.com, an estimated $29.9M trimmed.
- Steve Schonfeld's largest Q2 2020 buy was Claritev Corp: 75,000 shares worth $32.4M.
- Steve Schonfeld added most to TC Energy in Q2 2020, an estimated $113M increase.
- Steve Schonfeld's biggest Q2 2020 reduction was JD.com, cutting an estimated $29.9M.
- Steve Schonfeld fully exited Allergan plc in Q2 2020, selling an estimated $37M.
- Steve Schonfeld's ten largest holdings make up 13% of its $3.89B portfolio in Q2 2020.
- Steve Schonfeld opened 594 new positions and closed 486 in Q2 2020.
- Steve Schonfeld's portfolio value rose 145% quarter-over-quarter to $3.89B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.